Kuhn & Co Investment Counsel’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Kuhn & Co Investment Counsel's LLY Position: Q1 2026 in Review
Kuhn & Co Investment Counsel increased its Eli Lilly (LLY) stake by 0.62% in Q1 2026, buying an estimated $20.3K and bringing the position to 3,221 shares worth $2.96M. The position accounts for 1.91% of the portfolio, ranked #11.
Kuhn & Co Investment Counsel first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.44M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Kuhn & Co Investment Counsel held 3,221 shares of Eli Lilly worth $2.96M as of Q1 2026.
- Kuhn & Co Investment Counsel bought 20 Eli Lilly shares in Q1 2026, an estimated $20.3K.
- Eli Lilly made up 1.91% of Kuhn & Co Investment Counsel's portfolio in Q1 2026, its #11 holding.
- Kuhn & Co Investment Counsel first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
- Kuhn & Co Investment Counsel's Eli Lilly position peaked at $3.44M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Kuhn & Co Investment Counsel's 13F filing for Q1 2026, filed 12 May 2026.